Have there been any reported allergic reactions to lurbinectedin?

Have allergic reactions to lurbinectedin been reported?
Yes, allergic-type reactions have been documented in clinical use. These include rash, flushing, and shortness of breath that occur during or shortly after infusion, and they are listed among the adverse events in the prescribing information.

What triggers an allergic reaction during lurbinectedin infusion?
Infusion reactions are thought to stem from direct histamine release or immune recognition of the drug or its formulation components. Premedication with corticosteroids and antihistamines is standard to reduce the chance of these events.

How common are severe allergic reactions?
Grade 3 or higher hypersensitivity events remain uncommon, but mild-to-moderate skin or respiratory symptoms appear more frequently. Dose interruption or slowing the infusion usually resolves symptoms; permanent discontinuation is reserved for recurrent or severe cases.

Do patients with prior drug allergies face higher risk?
A history of multiple drug allergies or atopy can increase the likelihood of an infusion reaction, though no specific contraindications tied to other agents have been identified for lurbinectedin.

When do these reactions typically occur?
Most reported events happen during the first or second cycle. Later cycles tend to show fewer reactions once patients have received premedication and slower infusion rates.

Are there differences between lurbinectedin and similar agents?
Compared with older alkylating agents, lurbinectedin shows a lower rate of severe anaphylaxis but a similar profile of mild infusion reactions. Direct head-to-head data are limited.

How is an allergic reaction managed in practice?
Clinics monitor vital signs closely during the first 30 minutes of infusion. If symptoms appear, the infusion is stopped, supportive medications are given, and the drug may be restarted at a slower rate once symptoms resolve.

Does the drug carry special warnings on its label?
The FDA-approved label includes a precaution for hypersensitivity and advises premedication. No boxed warning for anaphylaxis is present.

What should patients watch for after leaving the clinic?
Delayed rashes or swelling can appear hours later. Patients are instructed to contact their care team promptly if breathing difficulty, widespread hives, or facial swelling develops.